2.3799

1.46% -0.0201

Immunitybio Inc (IBRX)

Overview News Price History Option Chain Financials Why IBRX Down? Discussions Forecast

Immunitybio Inc stock is traded at $2.3799, with a volume of 670.66K. It is down -1.46% in the last 24 hours and down -6.89% over the past month. ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.

Previous Close:

$2.40

Open:

$2.4

24h Volume:

670.66K

Relative Volume:

0.07

Market Cap:

$2.24B

Revenue:

$1.31M

Net Income/Loss:

$-597.65M

P/E Ratio:

-2.4535

EPS:

-0.97

Net Cash Flow:

$-425.62M

1W Performance:

-11.09%

1M Performance:

-6.89%

6M Performance:

-6.89%

1Y Performance:

-55.21%

1-Day Range:

$2.36

$2.40

1-Week Range:

$2.33

$2.66

52-Week Range:

$1.83

$5.88

Immunitybio Inc Stock (IBRX) Company Profile

Name

Immunitybio Inc

Sector

Healthcare (1137)

Industry

Biotechnology (635)

Phone

(844) 696-5235

Address

3530 JOHN HOPKINS COURT, SAN DIEGO

Employee

685

Twitter

Next Earnings Date

2024-11-06

Latest SEC Filings

IBRX's Discussions on Twitter

Compare IBRX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
IBRX Immunitybio Inc	2.375	2.36B	1.31M	-597.65M	-425.62M	-0.97
VRTX Vertex Pharmaceuticals Inc	426.98	109.11B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	646.84	68.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	446.11	60.25B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	828.51	50.39B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	184.51	40.44B	447.02M	-1.18B	-868.57M	-6.1812

Immunitybio Inc Stock (IBRX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-20-25	Upgrade	Piper Sandler	Neutral → Overweight
Mar-06-25	Initiated	H.C. Wainwright	Buy
Jan-10-25	Initiated	BTIG Research	Buy
May-12-23	Downgrade	Piper Sandler	Overweight → Neutral
Aug-03-22	Initiated	Jefferies	Buy

Immunitybio Inc Stock (IBRX) Latest News

03:55 AM

Why ImmunityBio Inc. (26CA) stock stays undervaluedJuly 2025 Sentiment & Fast Momentum Entry Tips - newser.com

03:55 AM

12:43 PM

What moving averages say about ImmunityBio Inc.Portfolio Value Report & Intraday High Probability Setup Alerts - newser.com

12:43 PM

Nov 02, 2025

ImmunityBio Inc. recovery potential after sell offMarket Sentiment Report & Community Verified Trade Alerts - newser.com

Nov 02, 2025

How ImmunityBio Inc. (26CA) stock responds to bond marketQuarterly Portfolio Summary & Growth Oriented Trading Recommendations - newser.com

Nov 02, 2025

Will ImmunityBio Inc. (26CA) stock justify high valuationQuarterly Portfolio Report & AI Enhanced Trade Execution Alerts - newser.com

Nov 02, 2025

ImmunityBio Inc Stock Analysis and ForecastStock Watchlist Updates & Small Investment Growth Tips - earlytimes.in

Nov 02, 2025

Why ImmunityBio Inc. (26CA) stock benefits from AI revolutionMarket Growth Report & Community Consensus Stock Picks - newser.com

Nov 02, 2025

How ImmunityBio Inc. (26CA) stock compares with tech leadersQuarterly Investment Review & Daily Growth Stock Tips - newser.com

Nov 02, 2025

Oct 31, 2025